Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001181431-13-005181)

Filing Details

Accession Number:
0001181431-13-005181
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-28 17:54:49
Reporting Period:
2013-01-24
Filing Date:
2013-01-28
Accepted Time:
2013-01-28 17:54:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486429 Elan Ezickson C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139		 Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-24 37,500 $0.00 62,993 No 4 A Direct
Common Stock Disposition 2013-01-28 1,150 $7.77 61,843 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right-to-buy) Acquisiton 2013-01-24 37,500 $0.00 37,500 $7.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,500 2023-01-24 No 4 A Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
  2. This option vests in equal monthly installments from January 1, 2013 through January 1, 2017.